These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2505698)

  • 1. The influence of fibronectin administration on the incidence of sepsis and septic mortality in severely injured patients. The Medical College of Georgia Fibronectin Research Group.
    Mansberger AR; Doran JE; Treat R; Hawkins M; May JR; Callaway BD; Horowitz M; Horowitz B; Shulman R
    Ann Surg; 1989 Sep; 210(3):297-306; discussion 306-7. PubMed ID: 2505698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial.
    Lundsgaard-Hansen P; Doran JE; Rubli E; Papp E; Morgenthaler JJ; Späth P
    Ann Surg; 1985 Dec; 202(6):745-59. PubMed ID: 3907549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibronectin and associated variables in surgical intensive care patients.
    Rubli E; Büssard S; Frei E; Lundsgaard-Hansen P; Pappova E
    Ann Surg; 1983 Mar; 197(3):310-7. PubMed ID: 6830338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of fibronectin and opsonic deficiency in patients. A controlled study.
    Saba TM; Blumenstock FA; Shah DM; Kaplan JE; Cho E; Scovill W; Stratton H; Newell J; Gottlieb M; Sedransk N
    Ann Surg; 1984 Jan; 199(1):87-96. PubMed ID: 6362585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations.
    Saba TM; Blumenstock FA; Shah DM; Landaburu RH; Hrinda ME; Deno DC; Holman JM; Cho E; Dayton C; Cardarelli PM
    Am J Med; 1986 Feb; 80(2):229-40. PubMed ID: 3946437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of fibronectin in transfusion medicine: focus on clinical studies.
    Powell FS; Doran JE
    Vox Sang; 1991; 60(4):193-202. PubMed ID: 1926827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced in vivo plasma fibronectin content of lung matrix during postoperative sepsis.
    Rebres RA; Cho E; Rotundo RF; Saba TM
    Am J Physiol; 1996 Sep; 271(3 Pt 1):L409-18. PubMed ID: 8843789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin in severe sepsis.
    Stevens LE; Clemmer TP; Laub RM; Miya F; Robbins L
    Surg Gynecol Obstet; 1986 Mar; 162(3):222-8. PubMed ID: 3082023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial analysis of fibronectin concentration in sera from septic patients.
    Bălună R; Tarnavschi R; Barac D; Belascu I; Georgescu H
    Med Interne; 1988; 26(1):85-90. PubMed ID: 3399819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.
    Saba TM; Niehaus GD; Scovill WA; Blumenstock FA; Newell JC; Holman J; Powers SR
    Ann Surg; 1983 Nov; 198(5):654-62. PubMed ID: 6416192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
    Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
    Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review. The intensive medical care relevance of plasma fibronectin].
    Lundsgaard-Hansen P; Doran JE; Rubli E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):435-45. PubMed ID: 2431963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin, prekallikrein, and fibronectin levels in surgical patients.
    Wilson RF; Mammen EF; Robson MC; Heggers JP; Soullier G; DePoli PA
    Arch Surg; 1986 Jun; 121(6):635-40. PubMed ID: 3486649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmatic concentrations of fibronectin as marker of clinical course among septic patients].
    Ruiz G; Veiga J; Luisa Gómez-Lus M; García-Carbajosa S; Prieto J
    Enferm Infecc Microbiol Clin; 2001 Mar; 19(3):93-8. PubMed ID: 11333585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients.
    Wilson RF; Farag A; Mammen EF; Fujii Y
    Am Surg; 1989 Jul; 55(7):450-6. PubMed ID: 2742228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin concentrations in plasma in peripheral vascular disease.
    Ejim OS; Fonseca V; Coumar A; Mathur S; Bell JL; Dandona P
    Clin Chem; 1988 Dec; 34(12):2426-9. PubMed ID: 3197279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fibronectin supplementation in endotoxic shock in the dog.
    Hauptman JG; Bednar EJ; Feldman BF; Davis AT; Emerson TE
    Circ Shock; 1987; 22(4):333-41. PubMed ID: 3652396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin depletion and microaggregate clearance following trauma.
    Rogers FB; Sheaff CM; Nolan PJ; Robin AP; Merlotti G; Barrett JA
    J Trauma; 1986 Apr; 26(4):339-42. PubMed ID: 3959139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibronectin levels in sepsis: influencing factors.
    Hesselvik JF
    Crit Care Med; 1987 Dec; 15(12):1092-7. PubMed ID: 3677761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.